Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
To validate the ability of the Methacetin Breath Test (MBT) to detect clinically significant portal hypertension (CSPH)/severe portal hypertension (SPH) defined as hepatic venous pressure gradient (HVPG) ≥ 10 mmHg and HVPG ≥ 12 mmHg respectively, in patients with non-alcoholic steatohepatitis (NASH) during the course of treatment with Conatus\'s investigational product emricasan/placebo.
Epistemonikos ID: 5add8f97ded1c3e9b4d2e7f6a62f54a45e6e3e65
First added on: May 21, 2024